Search
Medtronic's capsure sense lead, a device that is inserted into a heart pacemaker. Fees for device makers will more than double to $609 million, according to the Congressional Budget Office. Photo: Munshi Ahmed/Bloomberg

Medtronic's capsure sense lead, a device that is inserted into a heart pacemaker. Fees for device makers will more than double to $609 million, according to the Congressional Budget Office. Photo: Munshi Ahmed/Bloomberg
May 21, 2012
Article
FDA’s $6.4 Billion Plan for Quick Reviews Moves to Senate
« Back to Home